Clinical Trials on Retinal Diseases in Mexico

Total 7855 results

Asociación para Evitar la Ceguera en México

Terminated

Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Cystoid Macular Edema

Mexico
2C Tech Corp

Completed

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Retinitis Pigmentosa

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment

Proliferative Diabetic Retinopathy | Non Proliferative Diabetic Retinopathy

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Choroidal Neovascularization | Angioid Streaks

Mexico
Instituto Mexicano del Seguro Social
Sequana Medical N.V.

Recruiting

Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution

Chronic Kidney Diseases

Mexico
Allegro Ophthalmics, LLC

Completed

A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration

Macular Degeneration

Mexico
Instituto de Oftalmología Fundación Conde de Valenciana

Recruiting

Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis

Macular Holes

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

Epiretinal Membrane | Macular Hole

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment

Retinal Detachment

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Intravitreal Bevacizumab for Age-Related Macular Degeneration

Age Related Macular Degeneration

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez
Salvador López Gil; Armando Vázquez Rangel

Unknown

Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI) (CI-AKI)

Contrast-induced Nephropathy | Contrast-induced Acute Kidney Injury

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

Age Related Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO (MECROV)

Central Retinal Vein Occlusion | Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation (NEPAF)

Macular Edema | Macular Thickening

Mexico
Instituto Mexicano del Seguro Social

Completed

After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourniquet

Knee Osteoarthritis | Acute Kidney Injury | Arthroplasty, Replacement, Knee | Tourniquets

Mexico
Allegro Ophthalmics, LLC

Withdrawn

Safety Study of ALG- 1001 to Treat Diabetic Macular Edema

Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Bevacizumab and Retinal Vascular Occlusions

Vascular Occlusion | Edema Macular

Mexico
Asociación para Evitar la Ceguera en México

Terminated

The Effect of Transcorneal Stimulation in Cases of Central Retinal Artery Occlusion Using a New Waveform

Central Retinal Artery Occlusion

Mexico
Asociación para Evitar la Ceguera en México

Completed

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

Diabetic Macular Edema

Mexico
MejoraVisionMD
Maisonneuve-Rosemont Hospital; Retina and Genomics Institute

Recruiting

Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.

Retinitis Pigmentosa | Usher Syndromes | Cone Dystrophy | Retina; Dystrophy

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

POSTERIOR SUB-TENON'S Avastin

Diffuse Diabetic Macular Edema

Mexico
Bayer

Completed

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice (MAIA)

Retinal Disease

Mexico
Oraya Therapeutics, Inc.

Unknown

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | Wet Age-Related Macular Degeneration

Mexico
Laboratorios Sophia S.A de C.V.

Recruiting

Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema (PRO-169)

Diabetic Macular Edema

Colombia, Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Avastin for Post-photocoagulation Macular Edema

Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

Diffuse Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Comparison High-density Silicone Oils in Retinal Detachment

Retinal Detachment

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Efficacy of Retreatments With Intravitreal Bevacizumab

Age Related Macular Degeneration | Choroidal Neovascularization

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

Diffuse Diabetic Macular Edema

Mexico
Hospital Juarez de Mexico

Unknown

Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Contrast Sensitivity and Diabetic Macular Edema

DIABETES MELLITUS | DIABETIC RETINOPATHY | MACULAR EDEMA

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Diabetic Macular Edema | Diabetes Mellitus Type 2

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
Fundación Gonzalo Río Arronte

Recruiting

Postprandial Glucose Levels, Gut Microbiota and Supplementation With Functional Foods in Adults (PPGR)

Healthy | Nutritional and Metabolic Diseases

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Active, not recruiting

Personalized Nutrition Based on the Glycemic Response: Effect of Diet and Intestinal Microbiota

Obesity | Pre Diabetes

Mexico
Bayer

Completed

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America (AQUILA)

Macular Degeneration

Mexico, Argentina, Colombia, Costa Rica
Progen Pharmaceuticals

Completed

Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD

Age Related Macular Degeneration

United States, Mexico, Russian Federation
CMN "20 de Noviembre"

Completed

Distal Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention.

Coronary Artery Disease

Mexico
Hospital Infantil de Mexico Federico Gomez

Unknown

Comparison of the Impact of Diet vs Thiazide in BMD in Children With Idiopathic Hypercalciuria (HIC)

Nephrolithiasis | Hypercalciuria; Idiopathic

Mexico
Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto... and other collaborators

Recruiting

Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.

Breast Neoplasm

Mexico
Laboratorios Silanes S.A. de C.V.
Instituto Mexicano del Seguro Social

Completed

BIOAVAILABILITY OF GLI/METXR (4/850 mg) (GLMT12-SIL)

Healthy

Mexico
Laboratorios Silanes S.A. de C.V.
Instituto Mexicano del Seguro Social

Completed

BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study (GLMT13)

Healthy

Mexico
Instituto Nacional de Rehabilitacion
National Council of Science and Technology, Mexico

Completed

Robotic Gait Training in Spinal Cord Injury

Spinal Cord Injuries

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
Baxter México

Recruiting

Efficacy of Uremic Toxins Clearance With Expanded Hemodialysis

End Stage Renal Disease

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez

Completed

Conventional Hemodialysis Versus Post-Dilution Hemofiltration in Incident RRT (DA-VINCI)

Cognitive Impairment | Hemodialysis Complication | Cerebral Edema | Dialysis; Complications

Mexico
Coordinación de Investigación en Salud, Mexico
Hospital Infantil de Mexico Federico Gomez

Unknown

Effectiveness of Cinnamon on Insulin Resistance ( ECIRCCOS ) December 1, 2019 (ECIRCCOS)

Insulin Resistance | Obesity, Childhood | Insulin Sensitivity

Mexico
Centro Interdisciplinario de Ciencias de la Salud...

Unknown

Design of a Protocol for Obtaining Genomic DNA From Saliva (DPOGDNAS)

Periodontal Disease "Unrecognized Condition"

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

Diabetic Retinopathy

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Terminated

Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B

Patients With Fungic Infections

Mexico

Clinical Trials on Retinal Diseases in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations